Previous close | 160.81 |
Open | 161.16 |
Bid | 163.01 x 1200 |
Ask | 164.00 x 1000 |
Day's range | 160.74 - 164.25 |
52-week range | 130.96 - 182.89 |
Volume | |
Avg. volume | 5,736,312 |
Market cap | 290.015B |
Beta (5Y monthly) | 0.56 |
PE ratio (TTM) | 48.75 |
EPS (TTM) | 3.36 |
Earnings date | 25 Jul 2024 - 29 Jul 2024 |
Forward dividend & yield | 6.20 (3.79%) |
Ex-dividend date | 12 Apr 2024 |
1y target est | 183.20 |
Insightful Analysis of AbbVie's Strengths, Weaknesses, Opportunities, and Threats
Eli Lilly (LLY), Novo Nordisk (NVO), Pfizer (PFE) and AbbVie (ABBV) announce their first-quarter results.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.